IBDEI0T1 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14334,1,5,0)
 ;;=5^CLL,In Relapse
 ;;^UTILITY(U,$J,358.3,14334,2)
 ;;=^336466
 ;;^UTILITY(U,$J,358.3,14335,0)
 ;;=204.20^^90^858^114
 ;;^UTILITY(U,$J,358.3,14335,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14335,1,4,0)
 ;;=4^204.20
 ;;^UTILITY(U,$J,358.3,14335,1,5,0)
 ;;=5^Subacute LL w/o Remission
 ;;^UTILITY(U,$J,358.3,14335,2)
 ;;=^336852
 ;;^UTILITY(U,$J,358.3,14336,0)
 ;;=204.21^^90^858^116
 ;;^UTILITY(U,$J,358.3,14336,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14336,1,4,0)
 ;;=4^204.21
 ;;^UTILITY(U,$J,358.3,14336,1,5,0)
 ;;=5^Subacute LL,In Remission
 ;;^UTILITY(U,$J,358.3,14336,2)
 ;;=^267526
 ;;^UTILITY(U,$J,358.3,14337,0)
 ;;=204.22^^90^858^115
 ;;^UTILITY(U,$J,358.3,14337,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14337,1,4,0)
 ;;=4^204.22
 ;;^UTILITY(U,$J,358.3,14337,1,5,0)
 ;;=5^Subacute LL,In Relapse
 ;;^UTILITY(U,$J,358.3,14337,2)
 ;;=^336467
 ;;^UTILITY(U,$J,358.3,14338,0)
 ;;=205.02^^90^858^5
 ;;^UTILITY(U,$J,358.3,14338,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14338,1,4,0)
 ;;=4^205.02
 ;;^UTILITY(U,$J,358.3,14338,1,5,0)
 ;;=5^AML,In Relapse
 ;;^UTILITY(U,$J,358.3,14338,2)
 ;;=^336470
 ;;^UTILITY(U,$J,358.3,14339,0)
 ;;=205.12^^90^858^20
 ;;^UTILITY(U,$J,358.3,14339,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14339,1,4,0)
 ;;=4^205.12
 ;;^UTILITY(U,$J,358.3,14339,1,5,0)
 ;;=5^CML,In Relapse
 ;;^UTILITY(U,$J,358.3,14339,2)
 ;;=^336471
 ;;^UTILITY(U,$J,358.3,14340,0)
 ;;=284.81^^90^858^14
 ;;^UTILITY(U,$J,358.3,14340,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14340,1,4,0)
 ;;=4^284.81
 ;;^UTILITY(U,$J,358.3,14340,1,5,0)
 ;;=5^Aplastic Anemia d/t Drugs
 ;;^UTILITY(U,$J,358.3,14340,2)
 ;;=^335245
 ;;^UTILITY(U,$J,358.3,14341,0)
 ;;=284.89^^90^858^13
 ;;^UTILITY(U,$J,358.3,14341,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14341,1,4,0)
 ;;=4^284.89
 ;;^UTILITY(U,$J,358.3,14341,1,5,0)
 ;;=5^Aplastic Anemia d/t Chronic Disease
 ;;^UTILITY(U,$J,358.3,14341,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,14342,0)
 ;;=289.84^^90^858^119
 ;;^UTILITY(U,$J,358.3,14342,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14342,1,4,0)
 ;;=4^289.84
 ;;^UTILITY(U,$J,358.3,14342,1,5,0)
 ;;=5^Thrombocytopenia,Heparin Induced
 ;;^UTILITY(U,$J,358.3,14342,2)
 ;;=^336542
 ;;^UTILITY(U,$J,358.3,14343,0)
 ;;=V10.91^^90^858^67
 ;;^UTILITY(U,$J,358.3,14343,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14343,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,14343,1,5,0)
 ;;=5^H/O Neuroendocrine CA Tumor
 ;;^UTILITY(U,$J,358.3,14343,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,14344,0)
 ;;=V10.91^^90^858^66
 ;;^UTILITY(U,$J,358.3,14344,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14344,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,14344,1,5,0)
 ;;=5^H/O Malignant Neoplasm,Unspec
 ;;^UTILITY(U,$J,358.3,14344,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,14345,0)
 ;;=465.9^^90^859^70
 ;;^UTILITY(U,$J,358.3,14345,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14345,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,14345,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,14345,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,14346,0)
 ;;=462.^^90^859^61
 ;;^UTILITY(U,$J,358.3,14346,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14346,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,14346,1,5,0)
 ;;=5^Sore Throat
 ;;^UTILITY(U,$J,358.3,14346,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,14347,0)
 ;;=466.0^^90^859^3
 ;;^UTILITY(U,$J,358.3,14347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14347,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,14347,1,5,0)
 ;;=5^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,14347,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,14348,0)
 ;;=112.1^^90^859^79
 ;;^UTILITY(U,$J,358.3,14348,1,0)
 ;;=^358.31IA^5^2
